-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Susan E. McClory, MD, PhD1,2, Oishi Bardhan3*, Kelly S. Rome, PhD3*, Lanwei Xu3*, Phyllis A. Gimotty, PhD4*, Martha S. Jordan, PhD3,5* and Warren S. Pear, MD, PhD3,5

1Division of Oncology, Children's Hospital of Philadelphia, Havertown, PA
2Pediatrics, University of Pennsylvania, Philadelphia, PA
3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
4Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Institute for Immunology, University of Pennsylvania, Philadelphia, PA

Matthew R Lordo, BS1,2,3*, Thanh T Dinh, BS1,3*, Nikolas A Shilo, BS1*, Ekaterina S Altynova, BA1*, Erin G. Jeremy, MS1,2,3*, Aditi Varkey, BS1,4*, Patrick L Collins, PhD1,4*, Aharon G Freud, MD, PhD1,5 and Bethany L Mundy-Bosse, PhD1,6

1Pelotonia Institute for Immuno-Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2Medical Scientist Training Program, The Ohio State University, Columbus, OH
3Biomedical Science Graduate Program, The Ohio State University, Columbus, OH
4Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH
5Department of Pathology, The Ohio State University, Columbus, OH
6Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Sofie Lundgren, MD1,2*, Timo Järvinen1,2,3*, Mikko A Keränen, MD, PhD1,2,4*, Jason Theodoropoulos, BSc1,2*, Daehong Kim, PhD1,2*, Urpu Salmenniemi, MD5,6*, Gunilla Walldin7*, Paula Savola, MD, PhD1,2,8*, Tiina Kelkka, PhD1,2*, Hanna Rajala, MD, PhD1,2,4*, Pekka Ellonen, BSc9*, Eva Hellström-Lindberg, MD, PhD7, Maija Itälä-Remes, MD, PhD5*, Mikko Myllymäki, MD, PhD1,2*, Matti Kankainen, PhD1,2,3* and Satu Mustjoki, MD, PhD1,2,10

1Translational Immunology Research program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
2Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5Stem Cell Transplantation Unit, Turku University Hospital, Turku, Finland
6Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
7Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
8Clinical Chemistry, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
9HILIFE, Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
10iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Haley A Schmidt*, Lynn S. White* and Jeffrey J. Bednarski, MD, PhD

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO

Melanie Mumau1*, Sheila K Pierson, MSc1*, Michael Gonzalez, PhD1*, Scott Canna, MD2* and David C Fajgenbaum, MD, MBA, MSc1

1Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

Aditi Singh, MD1, Hemang Patel, PhD2*, Ahmed Abdalla, MD3, Talal Bazzi, MD2*, Mohamed Issa, MD2*, Hussein Gharib, MD4*, Laura Kohler, DO5, Natali Salaytah, BS2*, Nilamben Mangukia, MS2*, Hosam Hakim, MD1*, Carrie Lynn Dul, MD1*, Zyad Kafri, MD, MS1, Susan Szpunar, MPH, PhD2*, Daniel Lebovic, MD1* and Louis Saravolatz, MD2*

1Van Elslander Cancer Center, Ascension St. John Hospital, Grosse Pointe Woods, MI
2Ascension St. John Hospital, Detroit, MI
3University of South Alabama, Mobile, AL
422101 Moross Rd, Ascension St. John Hospital, Detroit, MI
5Van Elslander Cancer Center, St. John Hospital, Grosse Pointe Woods, MI

Matthew Kudek, MD1,2, Gang Xin, PhD1,3*, Sandra Lynn Holzhauer1,2*, Tony Alson, PhD1*, Jian Shen1,2*, Moujtaba Kasmani, PhD1,2*, Matthew Riese, MD, PhD1,2* and Weiguo Cui, MD, PhD1,2*

1Blood Research Institute, Versiti Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, Milwaukee, WI
3Ohio State University Medical Center, Columbus, OH

Kirsty Hillier, MD1,2, Suparna Kumar2*, Priyamvada Guha Roy3*, Hugues Allard-Chamard, MD, PhD4*, Jishnu Das, PhD5*, Jocelyn Farmer, MD, PhD2,6* and Shiv Pillai, MD, PhD2*

1Department of Pediatrics, Division of Pediatric Hematology-Oncology, Hassenfeld Children’s Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, NY
2Ragon Institute of MGH, MIT and Harvard, Harvard Medical School, Cambridge, MA
3Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
4Division of Rheumatology, Faculté de médecine et des sciences de la santé de l' Université de Sherbrooke et Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke, QC, Canada
5Department of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA
6Department of Allergy & Immunology, Massachusetts General Hospital, Boston, MA

Luis O Correa, BA1*, Rich Lee, B.A2*, Alexander Dils, BS3, Aditi I Vijendra4* and Shannon A. Carty, MD5,6

1Graduate Program in Immunology, University of Michigan, Ann Arbor, MI
2Internal Medicine Hematolog/Oncology, University of Michigan, Ann Arbor, MI
3Central Michigan University, Mt Pleasant, MI
4University of Michigan, Ann Arbor, MI
5Division of Hematology-Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI
6Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI

*signifies non-member of ASH